US2021155947A1PendingUtilityA1
Protein expression systems
Est. expiryJan 8, 2028(~1.5 yrs left)· nominal 20-yr term from priority
C12N 15/8203C12N 15/8216C12N 15/8257C12N 15/8258C07K 14/08C12N 15/82
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention is based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus, in which a target initiation site in the RNA-2 genome segment has been mutated. Deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase in foreign protein accumulation without the need for viral replication. Also provided are methods, vectors and systems, including the ‘hyper-translatable’ Cowpea Mosaic Virus (“CPMV-HT”) based protein expression system.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A gene expression construct comprising:
at least one fragment of the RNA-2 genome segment of Cowpea Mosaic Virus (CPMV) set forth in SEQ ID NO: 1,
wherein the fragment of the RNA-2 genome segment of CPMV consists essentially of at least 100 contiguous nucleotides of SEQ ID NO:1, and does not contain the target initiation site at positions 161-163 of SEQ ID NO: 1
a coding sequence for a protein heterologous to Cowpea Mosaic Virus,
wherein the coding sequence is operably linked to a functional translation initiation site, and
wherein the heterologous protein is expressed in a plant.
2 . The gene expression construct of claim 1 consisting essentially of a sequence starting with nucleotide 1 of SEQ ID NO:1 and up to target initiation site at positions 161-163.
3 . The gene expression construct of claim 1 consisting essentially of a mutated initiation site at positions 115-117, whereby the initiation site does not function as a translation initiation site.
4 . The gene expression construct of claim 3 , wherein the codon of positions 115-117 of SEQ ID NO:1 is GUG.
5 . The gene expression construct of claim 2 consisting essentially of a mutated initiation site at positions 115-117, whereby the initiation site does not function as a translation initiation site.
6 . The gene expression construct of claim 5 , wherein the codon of positions 115-117 of SEQ ID NO:1 is GUG.
7 . A gene expression construct comprising:
at least one fragment of the RNA-2 genome segment of Cowpea Mosaic Virus (CPMV) set forth in SEQ ID NO: 1,
wherein the fragment of the RNA-2 genome segment of CPMV consists essentially of a sequence starting with nucleotide 1 of SEQ ID NO:1 and up to target initiation site at positions 161-163, and the target initiation site at positions 161-163 of SEQ ID NO: 1 is mutated and does not function as a translation initiation site,
a coding sequence for a protein heterologous to Cowpea Mosaic Virus,
wherein the coding sequence is operably linked to a functional translation initiation site, and
wherein the heterologous protein is expressed in a plant.
8 . The gene expression construct of claim 7 , wherein the target initiation site at positions 161-163 of SEQ ID NO: 1 is deleted.
9 . The gene expression construct of claim 7 consisting essentially of a mutated initiation site at positions 115-117, whereby the initiation site does not function as a translation initiation site.
10 . The gene expression construct of claim 9 , wherein the codon of positions 115-117 of SEQ ID NO:1 is GUG.
11 . The gene expression construct of claim 6 consisting essentially of a mutated initiation site at positions 115-117, whereby the initiation site does not function as a translation initiation site.
12 . The gene expression construct of claim 11 , wherein the codon of positions 115-117 of SEQ ID NO:1 is GUG.
13 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 1 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
14 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 2 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
15 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 3 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
16 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 5 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
17 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 7 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
18 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 8 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
19 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 9 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
20 . A method for expressing a protein heterologous to CPMV in a plant comprising:
introducing the gene expression construct of claim 11 into a plant cell of the plant, whereby the heterologous protein is expressed in a plant.
21 . The method of claim 13 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
22 . The method of claim 14 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
23 . The method of claim 15 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
24 . The method of claim 16 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
25 . The method of claim 17 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
26 . The method of claim 18 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
27 . The method of claim 19 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
28 . The method of claim 20 , further comprising introducing into the plant cell a heterologous suppressor of gene silencing.
29 . The method of claim 13 , further comprising harvesting the heterologous protein.
30 . The method of claim 14 , further comprising harvesting the heterologous protein.
31 . The method of claim 15 , further comprising harvesting the heterologous protein.
32 . The method of claim 16 , further comprising harvesting the heterologous protein.
33 . The method of claim 17 , further comprising harvesting the heterologous protein.
34 . The method of claim 18 , further comprising harvesting the heterologous protein.
35 . The method of claim 19 , further comprising harvesting the heterologous protein.
36 . The method of claim 20 , further comprising harvesting the heterologous protein.
37 . The method of claim 21 , further comprising harvesting the heterologous protein.
38 . The method of claim 22 , further comprising harvesting the heterologous protein.
39 . The method of claim 23 , further comprising harvesting the heterologous protein.
40 . The method of claim 24 , further comprising harvesting the heterologous protein.
41 . The method of claim 25 , further comprising harvesting the heterologous protein.
42 . The method of claim 26 , further comprising harvesting the heterologous protein.
43 . The method of claim 27 , further comprising harvesting the heterologous protein.
44 . The method of claim 28 , further comprising harvesting the heterologous protein.
45 . The method of claim 29 further comprising preparing an extract of the heterologous protein.
46 . The method of claim 30 further comprising preparing an extract of the heterologous protein.
47 . The method of claim 31 further comprising preparing an extract of the heterologous protein.
48 . The method of claim 32 further comprising preparing an extract of the heterologous protein.
49 . The method of claim 33 further comprising preparing an extract of the heterologous protein.
50 . The method of claim 34 further comprising preparing an extract of the heterologous protein.
51 . The method of claim 35 further comprising preparing an extract of the heterologous protein.
52 . The method of claim 36 further comprising preparing an extract of the heterologous protein.
53 . The method of claim 37 further comprising preparing an extract of the heterologous protein.
54 . The method of claim 38 further comprising preparing an extract of the heterologous protein.
55 . The method of claim 39 further comprising preparing an extract of the heterologous protein.
56 . The method of claim 40 further comprising preparing an extract of the heterologous protein.
57 . The method of claim 41 further comprising preparing an extract of the heterologous protein.
58 . The method of claim 42 further comprising preparing an extract of the heterologous protein.
59 . The method of claim 43 further comprising preparing an extract of the heterologous protein.
60 . The method of claim 44 further comprising preparing an extract of the heterologous protein.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.